ONC$370.330.33%-1.23
After Hours: 370.330.00 0.00%
Beone Medicines Ltd Adr (ONC)
Date: 2026-10-30 16:00O: 369.77H: 376.45L: 368.49C: 370.33Vol: 261.8k
Beone Medicines Ltd Adr stock is traded at $370.33, with a volume of 261,761. It is down -0.33% in the last 24 hours and up +1.20% over the past month. Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up for 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has a global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes with AbbVie and AstraZeneca mainly. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.
Previous Close:
$371.56
Open:
$369.77
24h Volume:
261,761
Relative Volume:
0.72
Market Cap:
$41.89B
Revenue:
$5.76B
Net Income/Loss:
$514.49M
P/E Ratio:
82.64
EPS:
$4.48
Net Cash Flow:
$1.10B
1W Performance:
-1.93%
1M Performance:
+1.20%
6M Performance:
+25.42%
1Y Performance:
+20.15%
1-Day Range:
$368.49$376.45
1-Week Range:
$353.89$377.16
52-Week Range:
$253.95$388.66
Beone Medicines Ltd Adr Stock (ONC) Company Profile
Name
Beone Medicines Ltd AdrSector
HealthcareIndustry
BiotechnologyPhone
41-616851900Address
C/O BEONE MEDICINES I GMBH, BASEL, SwitzerlandCompare ONC vs VRTX, REGN, MRNA, ARGX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
Beone Medicines Ltd Adr Stock (ONC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Beone Medicines Ltd Adr Stock (ONC) Insider Trading
- Wang XiaodongOct 27 '26Chair, Scientific Advisory Brd
- Transaction
- Sale
- Cost
- $362.97
- #Shares
- 31,028
- Value ($)
- 11,262,131
- #Shares Total
- 0
- Wang XiaodongOct 13 '26Chair, Scientific Advisory Brd
- Transaction
- Sale
- Cost
- $350.99
- #Shares
- 31,027
- Value ($)
- 10,890,074
- #Shares Total
- 0
- Wang XiaodongOct 13 '26Chair, Scientific Advisory Brd
- Transaction
- Option Exercise
- Cost
- $36.90
- #Shares
- 31,027
- Value ($)
- 1,144,896
- #Shares Total
- 31,027
- CHAN LEESep 30 '26Officer
- Transaction
- Proposed Sale
- Cost
- $365.27
- #Shares
- 1,115
- Value ($)
- 407,276
- #Shares Total
- 0
- Lee Chan HenrySep 30 '26SVP, General Counsel
- Transaction
- Sale
- Cost
- $375.00
- #Shares
- 1,115
- Value ($)
- 418,125
- #Shares Total
- 0
- Wang XiaodongSep 28 '26Chair, Scientific Advisory Brd
- Transaction
- Option Exercise
- Cost
- $36.90
- #Shares
- 31,028
- Value ($)
- 1,144,933
- #Shares Total
- 31,028
- Wang XiaodongSep 28 '26Chair, Scientific Advisory Brd
- Transaction
- Sale
- Cost
- $364.79
- #Shares
- 31,028
- Value ($)
- 11,318,558
- #Shares Total
- 0
- Wang XiaodongSep 08 '26Chair, Scientific Advisory Brd
- Transaction
- Sale
- Cost
- $349.10
- #Shares
- 38,287
- Value ($)
- 13,366,092
- #Shares Total
- 0
- XIAODONG WANGSep 08 '26Director
- Transaction
- Proposed Sale
- Cost
- $358.26
- #Shares
- 131,370
- Value ($)
- 47,064,616
- #Shares Total
- 0
- Wang XiaodongSep 08 '26Chair, Scientific Advisory Brd
- Transaction
- Option Exercise
- Cost
- $36.90
- #Shares
- 31,027
- Value ($)
- 1,144,896
- #Shares Total
- 31,027
